Developed by Eli Lilly, retatrutide simultaneously targets GLP-1, GIP, and glucagon receptors, setting it apart from existing licensed treatments such as semaglutide and tirzepatide
Topiramate may have negative effects on growth in children TOPIRAMATE may slow height increases and weight gain in children and adolescents when used over a long period
Beyond its well-established role in normalizing plasma glucose in type 2 diabetes (47, 48), GLP-1 exerts mucosal protective effects, including promoting mucosal healing, pathogen defense, and facilitating weight loss (4953)
Injectable semaglutide typically produces more consistent blood levels and faster clinical results compared to its oral counterpart
It is synthesized by every cell of the body for the proper detoxification of metabolic waste products and is essential for healthy immune system function